Women's Kidney Health in Focus
Updated: September 17, 2026
- Globally, one in 10 women lives with chronic kidney disease (CKD), which is closely intertwined with cardiovascular risk as part of the cardiovascular-kidney-metabolic syndrome.
- The underrepresentation of women and the lack of sex-specific analyses and reporting in clinical trials of CKD therapies limit their informed applicability for women’s kidney health.
- This scientific statement highlights the pressing need for studying sex-specific pharmacokinetics and pharmacodynamics in CKD therapeutics to develop more sex-specific personalized drug dosing, selection, and risk management strategies.